CLOV vs DMAAR · rev $1.37B vs $1.8M cap
Clover Health Investments Corp (CLOV) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
DMAAR does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the CLOV and DMAAR stock pages for the full models.
Not investment advice.